The Correlation Between MAGE-A3, PRAME Polymorphism and Expression Levels of MAGE-A3 and PRAME in NSCLC Patients

计划入组 200 人 · 首次发布于 2016 年 3 月 21 日

Study of IMC-P115C in Advanced PRAME-Positive Cancers

计划入组 140 人 · 首次发布于 2025 年 9 月 4 日

PRAME Immunohistochemistry as an Adjunct for Evaluating Ambiguous Melanocytic Proliferation

计划入组 55 人 · 首次发布于 2021 年 10 月 22 日

PRAME (Anocca)

PRAME(Myrio Therapeutics)

PRAME-TCR-NK cells

PRIME MEDICINE

India

CRAME IAMPP

Uruguay

Medical Decision Logic, Inc.

United States

Castle Biosciences' Gene Expression Tests Show Superior Survival Prediction in Melanoma Patients

Real-World Study Validates DecisionDx-UM Test with PRAME Biomarker for Improved Uveal Melanoma Risk Stratification

PRAME-Directed TCR Cell Therapy Achieves Deep Remission in Pediatric Nephroblastoma Patient